Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_provenance.
- befree-20150227 importedOn "2015-02-27" NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_provenance.
- NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_assertion wasGeneratedBy ECO_0000203 NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_provenance.
- NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_assertion wasDerivedFrom befree-20150227 NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_provenance.
- NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_assertion SIO_000772 23588221 NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_provenance.
- NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_assertion evidence source_evidence_literature NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_provenance.
- NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_assertion description "[These preclinical data suggested that downregulation of Bcl-2 by RNAi in the gefitinib-resistant H1975 lung cancer cell line with T790M mutation enhanced the effects of gefitinib and may offer a novel therapeutic strategy for the treatment of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261929.RABg70dwPNV9T3q_cj1-n1eXz8CZWKtjzHOzhN9Qet_0k130_provenance.